Ceribell Execs to Present at March Investor Conferences
Event summary
- Ceribell CFO Scott Blumberg to present at Raymond James Institutional Investors Conference on March 2, 2026.
- Ceribell CEO Jane Chao and CFO Scott Blumberg to participate in fireside chat at TD Cowen Health Care Conference on March 3, 2026.
- Live and archived webcasts of presentations available on Ceribell's Investor Relations website.
- Ceribell focuses on point-of-care EEG technology for acute neurological conditions.
The big picture
Ceribell's participation in high-profile investor conferences underscores its strategic push to strengthen market positioning in the acute neurological care sector. The company's focus on AI-powered EEG technology aligns with broader industry trends toward rapid, portable diagnostic solutions. The upcoming presentations will be critical in shaping investor perceptions of Ceribell's growth trajectory and technological innovation.
What we're watching
- Market Positioning
- How Ceribell's presentations will emphasize its competitive edge in point-of-care EEG technology.
- Investor Sentiment
- Whether the conferences will boost investor confidence in Ceribell's growth prospects.
- Regulatory Landscape
- The pace at which Ceribell can expand its FDA-cleared applications for neurological conditions.
Our editorial coverage: